Position in OGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,489,682
+$792,251 QoQ
Shares Held
110,021
-5.5% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#127
of 626 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 47%
Shared 0%
None 53%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $3,483,940,248 across 16 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
781,929 | $937,869,169 | |
| 2 | JNJ |
Johnson & Johnson
|
2,675,500 | $679,496,724 | |
| 3 | ABBV |
AbbVie Inc.
|
1,621,115 | $407,937,369 | |
| 4 | AZN |
Astrazeneca PLC
|
2,033,587 | $385,608,756 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,578,024 | $331,276,081 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,215,423 | $242,892,664 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,070,731 | $135,276,147 | |
| 8 | PFE |
Pfizer Inc
|
5,482,863 | $132,027,333 |
All Filings in OGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,489,682 | 110,021 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $697,431 | 116,433 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $815,981 | 113,805 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $20,755,786 | 1,943,426 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $15,956,277 | 1,648,376 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $27,814,470 | 1,867,997 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $29,781,149 | 1,996,056 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $49,532,731 | 2,589,270 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $44,549,397 | 2,152,145 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $30,728,183 | 1,634,478 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $19,558,302 | 1,356,332 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $16,014,197 | 922,477 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $19,390,234 | 931,775 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $12,686,733 | 539,402 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $7,614,413 | 272,625 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $5,825,849 | 248,968 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $12,025,594 | 356,314 | Shares | Defined | 2022-07-29 | |
| 2021-12-31 | $9,145,532 | 300,346 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $8,870,741 | 270,532 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $6,139,206 | 202,882 | Shares | Defined | 2021-08-04 | |
| No filing history on record for this holder in this stock. | ||||||